Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ringerfundin is a balanced full electrolyte solution used for intravenous infusion therapy. It has an isotonic electrolyte composition that closely resembles human plasma, making it suitable for fluid replacement and correction of acid-base imbalances. ## Composition and Properties Ringerfundin contains a balanced mixture of electrolytes including sodium, potassium, calcium, magnesium, and chloride, along with metabolizable anions[1][6]. Its composition is specifically designed to match the electrolyte profile of human plasma, which helps prevent electrolyte imbalances during fluid therapy[1][3]. Unlike some other crystalloid solutions, Ringerfundin's essential anions are metabolized in all organs and muscles with minimum oxygen consumption[1][7]. This metabolic stability is a key advantage, as it doesn't increase oxygen consumption or total energy requirements during administration[7]. ## Clinical Uses Ringerfundin is primarily indicated for: 1. Replacement of extracellular fluid losses in cases of isotonic dehydration[6][9] 2. Treatment of conditions with high acidity in the blood (acidosis) or where acidosis is imminent[5][6] 3. Fluid resuscitation in critical care settings, including septic shock[3] ## Clinical Benefits Research has demonstrated several advantages of Ringerfundin over other crystalloid solutions: - Better preservation of acid-base balance compared to alternatives like Ringer's lactate[3] - Prevention of dilutional acidosis during fluid therapy[6] - Being lactate-free, it allows lactate to be used as a marker of hypoxia[6] - Lower increase in serum chloride levels compared to Ringer's lactate[3] - Better clearance of lactate after administration[3] ## Administration Ringerfundin is administered intravenously, with dosage determined by the patient's clinical condition, weight, and laboratory parameters[5]. The solution should be used with caution in patients with certain conditions, including: - Increased blood volume - Severe heart or kidney disease - High potassium or calcium levels in the blood - Alkalosis (too much alkalinity in the blood)[5] Regular monitoring of fluid balance, electrolytes, and acid-base status is recommended during treatment to ensure proper balance is maintained[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ringerfundin.